A groundbreaking study shows that GLP-1 diabetes drugs may reduce the risk of obesity-related cancers by 7% compared to DPP-4 inhibitors, particularly in women. Discover the implications for diabetes treatment!
Researchers have developed a groundbreaking method for inserting large genes into specific locations in human cells, potentially transforming the field of gene therapy and opening new avenues in medical research.
A groundbreaking study reveals the link between 'brain fog' in long COVID patients and changes in brain chemistry, providing scientific proof for millions suffering from neurological symptoms.
In a heated Capitol Hill hearing, Health Secretary Robert F. Kennedy Jr. faced fierce criticism from House Democrats over his drastic budget cuts to federal health agencies, sparking a fiery debate on the future of medical research funding.
At just 35, Eric faced a dire cancer diagnosis, but thanks to groundbreaking research and treatment, he defied the odds. Discover how federal funding is crucial for cancer breakthroughs and the fight against rare conditions like EDS.
A groundbreaking DNA study reveals that Japan's ancestry is shaped by three ancient groups, not just two. This discovery could reshape our understanding of genetics and future medical research.
New research reveals that HIV drugs known as NRTIs can reduce the risk of developing Alzheimer’s disease by 6% to 13% annually. Scientists urge for clinical trials to explore this promising link.
Emily Kramer-Golinkoff, a cystic fibrosis patient with a rare mutation, highlights the struggles of those left behind as gene therapies show promise for others. Her journey underscores the need for equitable treatments in rare genetic conditions.
A groundbreaking blood test developed by researchers may change how Alzheimer's is diagnosed and treated, providing insights into the disease's progression and helping identify suitable medications.
In a controversial move, NIH officials may be pushing to eliminate mRNA vaccine technology from grant applications, signaling a potential halt in vital medical research. Scientists express fears over job security and funding.
